Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
66,281,493
-
Share change
-
+6,977,912
-
Total reported value
-
$1,963,259,202
-
Put/Call ratio
-
27%
-
Price per share
-
$29.62
-
Number of holders
-
237
-
Value change
-
+$212,206,754
-
Number of buys
-
134
-
Number of sells
-
98
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2017
As of 31 Mar 2017,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,281,493 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Consonance Capital Management LP, Bank of New York Mellon Corp, STATE STREET CORP, JANUS CAPITAL MANAGEMENT LLC, Van Berkom & Associates Inc., ABERDEEN ASSET MANAGEMENT PLC/UK, and DIMENSIONAL FUND ADVISORS LP.
This page lists
238
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.